Skip to content

Atropine / Carzenide / Dipyrone

Published: July 27, 2026Updated: August 27, 2026

This multi-ingredient medication combines atropine (an anticholinergic agent), carzenide (a carbonic anhydrase inhibitor), and dipyrone (a pain-relieving and fever-reducing agent). The combination is typically used for managing pain, fever, and related conditions, with each component potentially addressing different aspects of symptom relief. This formulation may be prescribed in regions where such combination products are available for specific therapeutic purposes.

Quick summary

A combination analgesic/anticholinergic medication used for pain and fever management with effects from its three active ingredients.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

RxNorm
1008698
Generic
Atropine / Carzenide / Dipyrone
Class
multi-ingredient
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

This combination medication is used for the treatment of pain and fever. Dipyrone provides analgesic and antipyretic effects, while atropine adds anticholinergic properties and carzenide contributes carbonic anhydrase inhibition. The specific approved uses may vary by country.

Each ingredient contributes different mechanisms: dipyrone inhibits prostaglandin synthesis and may affect opioid receptors; atropine blocks muscarinic acetylcholine receptors; and carzenide inhibits carbonic anhydrase enzymes. Together, they provide multi-faceted relief for pain and fever with additional anticholinergic effects.

This combination should be used under medical supervision. Dipyrone has been associated with rare but serious blood disorders. Atropine may cause dry mouth, blurred vision, and urinary retention. Carzenide can affect electrolyte balance. Use is typically avoided in pregnancy, breastfeeding, and in patients with certain medical conditions. Consult a healthcare provider for appropriate use and monitoring.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy